100
Participants
Start Date
February 15, 2025
Primary Completion Date
February 15, 2026
Study Completion Date
February 15, 2026
Eschscholzia tablets
"The intervention will be provided as swallowable Eschscholzia tablets (1.0 g) containing 0.503g Eschscholzia californica Herba rec. tinct. conc. as the active pharmaceutical ingredient (API) corresponding 600 mg powdered herbal material."
Placebo Tablets
A placebo tablet will be provided that matches the verum in its optical and sensorial properties and posology. Contains: microcrystalline cellulose, Colloidal anhydrous silica, glycerol distearate, caramel couleur and colorants.
Diagnostics and Consultation Center Convex, Sofia
DCC Convex Ltd.
UNKNOWN
A. Vogel AG
INDUSTRY